SB325,7,2019
i. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-methoxyphenylacetyl)indole,
20commonly known as cannabipiperidiethanone;
SB325,8,221
5. Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by
22substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl,
23alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
242-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
251-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
1whether or not substituted in the cyclohexyl ring to any extent. Substances specified
2under this subdivision include:
SB325,8,43
a. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol,
4commonly known as CP 47,497;
SB325,8,65
b. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol,
6commonly known as CP 47,497 C8 homologue, or cannabicyclohexanol;
SB325,8,147
6. Any compound structurally derived from 3-(benzoyl)indole by substitution
8at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
9cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
102-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
111-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
12whether or not further substituted in the indole ring to any extent and whether or
13not substituted in the phenyl ring to any extent. Substances specified under this
14subdivision include:
SB325,8,1515
a. 1-pentyl-3-(2-iodobenzoyl)indole, commonly known as AM-679;
SB325,8,1616
b. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole, commonly known as AM-694;
SB325,8,1717
c. 1-pentyl-3-(4-methoxybenzoyl)indole, commonly known as RCS-4;
SB325,8,1918
d. 1-butyl-3-(4-methoxybenzoyl)indole, commonly known as RCS-4-C4
19homologue;
SB325,8,2120
e. 1-pentyl-3-(2-methoxybenzoyl)indole, commonly known as RCS-4
212-methoxy isomer;
SB325,8,2322
f. 1-butyl-3-(2-methoxybenzoyl)indole, a C4 homologue, 2-methoxy isomer
23of RCS-4;
SB325,8,2524
g. 1-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)indole,
25commonly known as pravadoline, or WIN 48,098;
SB325,9,3
1h.
21-[2-(4-(morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodo-indole,
3commonly known as 6-iodopravadoline, or AM-630;
SB325,9,54
i. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodo-5-nitrobenzoyl)indole,
5commonly known as AM-1241;
SB325,9,76
j. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)indole,
7commonly known as AM-2233;
SB325,9,158
7. Any compound structurally derived from 3-adamantoylindole by
9substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl,
10alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
112-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
121-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
13whether or not further substituted in the indole ring to any extent, whether or not
14substituted in the adamantyl ring to any extent. Substances specified under this
15subdivision include:
SB325,9,1716
a. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-adamantoyl)indole,
17commonly known as AM-1248;
SB325,9,1818
b. 1-pentyl-3-(1-adamantoyl)indole, commonly known as AB-001;
SB325,9,2419
8. Any compound structurally derived from 3-(cyclopropoyl)indole by
20substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl,
21alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
222-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
231-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
24whether or not further substituted in the indole ring to any extent, whether or not
1substituted in the cyclopropyl ring to any extent. Substances specified under this
2subdivision include:
SB325,10,43
a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly known as
4UR-144;
SB325,10,65
b. 1-(5-chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly
6known as 5Cl-UR-144;
SB325,10,87
c. 1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole, commonly
8known as XLR-11;
SB325,10,109
d. 1-[2-(4-morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole,
10commonly known as A-796,260;
SB325,10,1311
e.
121-[(tetrahydropyran-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole,
13commonly known as A-834,735;
SB325,10,2114
9. Any compound structurally derived from
15N-adamantyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of
16the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
17cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
181-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
19(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
20indole ring to any extent, whether or not substituted in the adamantyl ring to any
21extent. Substances specified under this subdivision include:
SB325,10,2322
a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide, commonly known
23as 2NE1;
SB325,10,2524
b. N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide,
25commonly known as STS-135;
SB325,11,8
110. Any compound structurally derived from
2N-adamantyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom
3of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
4cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
51-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
6(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
7indazole ring to any extent, whether or not substituted in the adamantyl ring to any
8extent. Substances specified under this subdivision include:
SB325,11,109
a. 1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly
10known as AKB48;
SB325,11,1211
b.
1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-carboxamide,
12commonly known as 5F-AKB48.
SB325,11,2013
11. Any compound structurally derived from
14N-naphthyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom
15of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
16cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
171-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
18(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
19indazole ring to any extent, whether or not substituted in the naphthyl ring to any
20extent.
SB325,11,2221
12. [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester, commonly known as
22URB-602;
SB325,12,223
13.
24[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,
16a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate, commonly known as CP
250,556-1;
SB325,12,53
14.
4(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,1
50a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-210;
SB325,12,86
15.
7(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10
8a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-211;
SB325,12,119
16.
103-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pe
11ntyl-2,5-cyclohexadiene-1,4-dione, commonly known as HU-331;
SB325,12,1412
17.
13((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo
14[c]chromen-9-yl)methanol, commonly known as JWH-051;
SB325,12,1615
18. (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro
16-6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as JWH-133;
SB325,12,1917
19.
18(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-trimethylbutyl]-6a,7,10,1
190a-tetrahydrobenzo[c]chromene, commonly known as JWH-359;
SB325,12,2120
20. Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone, commonly
21known as CB-13;
SB325,12,2322
21. N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecamide,
23commonly known as CB-25;
SB325,12,2524
22. N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecamide, commonly
25known as CB-52;
SB325,13,3
123.
2N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroqui
3noline-3-carboxamide, commonly known as JTE-907;
SB325,13,64
24.
5N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethy
6lcyclopropane-1-carboxamide, commonly known as A-836,339;
SB325,13,97
25.
8Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methano
9ne, commonly known as WIN 56,098;
SB325,13,1110
26. 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one,
11commonly known as URB-754;
SB325,13,1312
27. [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate, commonly
13known as URB-597;
SB325,13,1614
28.
15(-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfon
16ate, commonly known as BAY 38-7271.
SB325,13,2417
29. Any compound structurally derived from 1H-indole-3-carboxylic acid
18quinolinyl ester by substitution at the nitrogen atom of the indole ring by alkyl,
19haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
201-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
211-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
22(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
23indole ring to any extent, whether or not substituted in the quinoline ring to any
24extent. Substances specified under this subdivision include:
SB325,14,2
1a. 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known
2as PB-22;
SB325,14,43
b. 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester,
4commonly known as 5F-PB-22;
SB325,14,65
c. 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester,
6commonly known as BB-22.
SB325,14,147
30. Any compound structurally derived from
8N-naphthyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of the
9indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
10cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
111-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
12(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
13indole ring to any extent, whether or not substituted in the naphthyl ring to any
14extent. Substances specified under this subdivision include:
SB325,14,1615
a. 1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as
16NNEI or MN-24;
SB325,14,1817
b. 1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly
18known as 5F-NNEI or 5F-MN-24.
SB325,15,219
31. Any compound structurally derived from 3-(pyridinoyl)indole by
20substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,
21alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
222-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
231-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
24whether or not further substituted in the indole ring to any extent, whether or not
1substituted in the pyridine ring to any extent. Substances specified under this
2subdivision include:
SB325,15,33
a. 1-pentyl-3-(3-pyridinoyl)indole;
SB325,15,44
b. 1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.
SB325,7
5Section
7. 961.14 (4) (te), (th), (tL), (tp), (tr), (tu) and (ty) of the statutes are
6repealed.
SB325,8
7Section
8. 961.14 (4) (uv) of the statutes is created to read:
SB325,15,98
961.14
(4) (uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone,
9commonly known as methoxetamine.
SB325,9
10Section
9. 961.14 (4) (wa) of the statutes is created to read:
SB325,15,1211
961.14
(4) (wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known as
12DOI.
SB325,10
13Section
10. 961.14 (4) (wb) of the statutes is created to read:
SB325,15,1514
961.14
(4) (wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as
15DOC.
SB325,11
16Section
11. 961.14 (4) (wk) of the statutes is created to read:
SB325,15,1817
961.14
(4) (wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as
182C-E.
SB325,12
19Section
12. 961.14 (4) (wL) of the statutes is created to read:
SB325,15,2120
961.14
(4) (wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known
21as 2C-D.
SB325,13
22Section
13. 961.14 (4) (wm) of the statutes is created to read:
SB325,15,2423
961.14
(4) (wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known
24as 2C-C.
SB325,14
25Section
14. 961.14 (4) (wn) of the statutes is created to read:
SB325,16,2
1961.14
(4) (wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known
2as 2C-T-2.
SB325,15
3Section
15. 961.14 (4) (wo) of the statutes is created to read:
SB325,16,54
961.14
(4) (wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly
5known as 2C-T-4.
SB325,16
6Section
16. 961.14 (4) (wp) of the statutes is created to read:
SB325,16,77
961.14
(4) (wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
SB325,17
8Section
17. 961.14 (4) (wq) of the statutes is created to read:
SB325,16,109
961.14
(4) (wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as
102C-N.
SB325,18
11Section
18. 961.14 (4) (wr) of the statutes is created to read:
SB325,16,1312
961.14
(4) (wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly
13known as 2C-P.
SB325,19
14Section
19. 961.14 (4) (ws) of the statutes is created to read:
SB325,16,1915
961.14
(4) (ws) Any compound structurally derived from
16N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen
17atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide
18or nitro substituents, or by any combination of these modifications. Substances
19specified under this paragraph include:
SB325,16,2220
1.
212-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
22commonly known as 25I-NBOMe.
SB325,16,2523
2.
242-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
25commonly known as 25C-NBOMe.
SB325,17,3
13.
22-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
3commonly known as 25B-NBOMe.
SB325,17,54
4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
5commonly known as 25E-NBOMe.
SB325,20
6Section
20. 961.14 (4) (wv) of the statutes is created to read:
SB325,17,87
961.14
(4) (wv) N,N-diallyl-5-methoxytryptamine, commonly known as
85-MeO-DALT.